In this CRA Competition Memo, Geoff Edwards discusses the Ofcom decision and distinguishes between a techincal margin squeeze and an abuse of a dominant position.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
